PortfoliosLab logoPortfoliosLab logo
FTXH vs. RDVY
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FTXH vs. RDVY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Nasdaq Pharmaceuticals ETF (FTXH) and First Trust Rising Dividend Achievers ETF (RDVY). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

The year-to-date returns for both investments are quite close, with FTXH having a 17.64% return and RDVY slightly higher at 18.21%.


FTXH

1D
-0.77%
1M
-1.43%
6M
12.69%
YTD
17.64%
1Y
49.44%
3Y*
15.53%
5Y*
9.04%
10Y*
ALL TIME*
8.02%

RDVY

1D
0.81%
1M
2.01%
6M
12.29%
YTD
18.21%
1Y
31.80%
3Y*
20.39%
5Y*
13.07%
10Y*
16.08%
ALL TIME*
13.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$132.42M$64.10M$22.26M
$79.27M$78.43M$84.11M

FTXH vs. RDVY - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
FTXH
First Trust Nasdaq Pharmaceuticals ETF
17.64%24.15%2.98%-1.41%2.55%6.14%11.73%22.13%-9.51%19.44%
RDVY
First Trust Rising Dividend Achievers ETF
18.21%18.90%16.41%20.38%-13.27%31.14%13.47%37.71%-9.92%22.75%

Correlation

The correlation between FTXH and RDVY is 0.32, which is low. Their historical price movements had little consistent relationship.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.32

Correlation (3Y)
Balances recent behavior with more history.

0.50

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.51

Correlation (All Time)
Calculated using the full available price history since Sep 22, 2016

0.48

The correlation between FTXH and RDVY shifts across timeframes, from 0.32 (1 year) to 0.51 (5 years), reflecting how their relationship changes across market environments.

FTXH vs. RDVY - Sectors Allocation Comparison


Sectors
FTXH
RDVY

Healthcare

100.0%
5.6%

Basic Materials

-

-

Communication Services

-

4.2%

Consumer Cyclical

-

11.1%

Consumer Defensive

-

2.8%

Energy

-

2.8%

Financial Services

-

38.9%

Industrials

-

12.5%

Real Estate

-

-

Technology

-

19.4%

Utilities

-

1.4%

Healthcare

FTXH
100.0%
RDVY
5.6%

Basic Materials

FTXH

-

RDVY

-

Communication Services

FTXH

-

RDVY
4.2%

Consumer Cyclical

FTXH

-

RDVY
11.1%

Consumer Defensive

FTXH

-

RDVY
2.8%

Energy

FTXH

-

RDVY
2.8%

Financial Services

FTXH

-

RDVY
38.9%

Industrials

FTXH

-

RDVY
12.5%

Real Estate

FTXH

-

RDVY

-

Technology

FTXH

-

RDVY
19.4%

Utilities

FTXH

-

RDVY
1.4%

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FTXH vs. RDVY — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

FTXH
FTXH Risk / Return Rank: 9595
Overall Rank
FTXH Sharpe Ratio Rank: 9595
Sharpe Ratio Rank
FTXH Sortino Ratio Rank: 9595
Sortino Ratio Rank
FTXH Omega Ratio Rank: 9393
Omega Ratio Rank
FTXH Calmar Ratio Rank: 9696
Calmar Ratio Rank
FTXH Martin Ratio Rank: 9494
Martin Ratio Rank

RDVY
RDVY Risk / Return Rank: 8888
Overall Rank
RDVY Sharpe Ratio Rank: 8888
Sharpe Ratio Rank
RDVY Sortino Ratio Rank: 8989
Sortino Ratio Rank
RDVY Omega Ratio Rank: 8585
Omega Ratio Rank
RDVY Calmar Ratio Rank: 8787
Calmar Ratio Rank
RDVY Martin Ratio Rank: 9090
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

FTXH vs. RDVY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Nasdaq Pharmaceuticals ETF (FTXH) and First Trust Rising Dividend Achievers ETF (RDVY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


FTXHRDVYDifference
Sharpe ratioReturn per unit of total volatility

+0.73

Sortino ratioReturn per unit of downside risk

+1.20

Omega ratioGain probability vs. loss probability

1.48

1.38

+0.11

Calmar ratioReturn relative to maximum drawdown

6.65

3.54

+3.12

Martin ratioReturn relative to average drawdown

19.78

14.83

+4.95

FTXH vs. RDVY - Sharpe Ratio Comparison

The current FTXH Sharpe Ratio is 2.92, which is higher than the RDVY Sharpe Ratio of 2.19. The chart below compares the historical Sharpe Ratios of FTXH and RDVY, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

FTXH vs. RDVY - Drawdown Comparison

The maximum FTXH drawdown since its inception was -32.11%, smaller than the maximum RDVY drawdown of -40.60%. Use the drawdown chart below to compare losses from any high point for FTXH and RDVY.


Loading charts...

Drawdown Indicators


FTXHRDVYDifference

Max Drawdown

Largest peak-to-trough decline

-32.11%

-40.60%

+8.49%

Max Drawdown (1Y)

Largest decline over 1 year

-7.47%

-9.04%

+1.57%

Max Drawdown (3Y)

Largest decline over 3 years

-19.51%

-19.11%

-0.40%

Max Drawdown (5Y)

Largest decline over 5 years

-19.51%

-25.32%

+5.81%

Max Drawdown (10Y)

Largest decline over 10 years

-40.60%

Current Drawdown

Current decline from peak

-2.77%

0.00%

-2.77%

Average Drawdown

Average peak-to-trough decline

-5.76%

-4.95%

-0.81%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.51%

2.15%

+0.36%

Volatility

FTXH vs. RDVY - Volatility Comparison

First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a higher volatility of 4.91% compared to First Trust Rising Dividend Achievers ETF (RDVY) at 3.55%. This indicates that FTXH's price experiences larger fluctuations and is considered to be riskier than RDVY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FTXHRDVYDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.91%

3.55%

+1.36%

Volatility (6M)

Calculated over the trailing 6-month period

12.81%

11.40%

+1.41%

Volatility (1Y)

Calculated over the trailing 1-year period

17.04%

14.64%

+2.40%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

16.53%

18.93%

-2.40%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.43%

21.03%

-2.60%

FTXH vs. RDVY - Expense Ratio Comparison

FTXH has a 0.60% expense ratio, which is higher than RDVY's 0.47% expense ratio.


Dividends

FTXH vs. RDVY - Dividend Comparison

FTXH's dividend yield for the trailing twelve months is around 1.10%, more than RDVY's 0.83% yield.


PositionTTM20252024202320222021202020192018201720162015
FTXH
First Trust Nasdaq Pharmaceuticals ETF
1.10%1.41%1.66%1.55%1.11%1.03%0.82%0.67%0.91%2.18%0.19%0.00%
RDVY
First Trust Rising Dividend Achievers ETF
0.83%1.11%1.64%2.09%2.21%1.04%1.53%1.55%1.68%1.25%2.07%2.14%

Frequently Asked Questions


FTXH and RDVY have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

FTXH has higher volatility (4.91%) compared to RDVY (3.55%). In terms of maximum drawdown, FTXH dropped -32.11% vs RDVY's -40.60%.

On 5-year performance, RDVY leads with 13.07% vs 9.04% for FTXH. On fees, RDVY is cheaper at 0.47% per year. On volatility, RDVY has been the lower-risk option at 3.55%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 5-year period, RDVY has performed better with a 13.07% return vs 9.04%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

RDVY is cheaper with a 0.47% expense ratio, compared with 0.60% for FTXH.

FTXH has the higher dividend yield at 1.10%, compared with 0.83% for RDVY.

FTXH is categorized as Health & Biotech Equities, while RDVY is Dividend. FTXH tracks Nasdaq U.S. Smart Pharmaceuticals Index, while RDVY tracks Nasdaq US Rising Dividend Achievers Index. Their fees differ too: 0.60% for FTXH and 0.47% for RDVY.

FTXH currently has the higher Sharpe Ratio (2.92 vs 2.19), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for FTXH and RDVY

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer